Fayez Sarofim & Co

Position in NVO — Novo Nordisk A S

CIK 937729 Houston, TX

Back to NVO Full portfolio

Position in NVO

as of Jun 30, 2026 · filed Aug 17, 2026 Compact

Position Value

$140,200,529

+$15,416,676 QoQ

Shares Held

2,924,500

-13.9% QoQ

Ownership

0.066%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

#28

of 1,348 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Fayez Sarofim & Co holds $1,793,961,393 across 10 Drug Manufacturers - General names. NVO ranks #5 (7.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	2,876,785	$723,914,175
2	LLY	ELI LILLY & Co	425,688	$510,582,998
3	MRK	Merck & Co., Inc.	1,664,909	$213,940,806
4	JNJ	Johnson & Johnson	688,542	$174,869,011
5	NVO	Novo Nordisk A S This page	2,924,500	$140,200,529
6	AMGN	Amgen Inc	54,394	$19,697,155
7	PFE	Pfizer Inc	233,339	$5,618,802
8	NVS	Novartis AG	28,162	$4,413,548

All Filings in NVO

Export CSV

26 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$140,200,529	2,924,500	-13.9%	Shares	Defined	2026-08-17
2026-03-31	$124,783,853	3,395,479	-19.8%	Shares	Defined	2026-05-15
2025-12-31	$215,464,028	4,234,749	-42.4%	Shares	Defined	2026-02-13
2025-09-30	$408,050,541	7,353,587	-30.0%	Shares	Defined	2025-11-14
2025-06-30	$724,962,749	10,503,662	-6.3%	Shares	Defined	2025-08-14
2025-03-31	$778,595,929	11,212,499	-1.5%	Shares	Defined	2025-05-12
2024-12-31	$979,293,053	11,384,481	-6.8%	Shares	Defined	2025-02-14
2024-09-30	$1,454,692,239	12,217,118	-2.7%	Shares	Defined	2024-11-14
2024-06-30	$1,791,685,039	12,552,088	+6.2%	Shares	Defined	2024-08-14
2024-03-31	$1,517,153,470	11,815,837	+0.0%	Shares	Defined	2024-05-14
2023-12-31	$1,222,163,575	11,814,051	+1.8%	Shares	Defined	2024-02-15
2023-09-30	$1,055,264,484	11,603,964	+126.7%	Shares	Defined	2023-11-15
2023-06-30	$828,518,622	5,119,685	-3.0%	Shares	Defined	2023-08-14
2023-03-31	$840,316,011	5,280,357	+3.2%	Shares	Defined	2023-05-11
2022-12-31	$692,449,379	5,116,369	-1.9%	Shares	Defined	2023-02-13
2022-09-30	$519,879,701	5,218,104	+9.4%	Shares	Defined	2022-11-15
2022-06-30	$531,278,627	4,767,824	+0.0%	Shares	Defined	2022-08-12
2022-03-31	$529,393,450	4,767,163	-1.3%	Shares	Defined	2022-05-16
2021-12-31	$541,204,160	4,832,180	-1.8%	Shares	Defined	2022-02-11
2021-09-30	$472,587,526	4,922,274	-0.2%	Shares	Defined	2021-11-15
2021-06-30	$413,058,307	4,930,862	-0.7%	Shares	Defined	2021-08-13
2021-03-31	$334,764,231	4,965,355	-0.4%	Shares	Defined	2021-05-13
2020-12-31	$348,093,771	4,983,447	-0.3%	Shares	Defined	2021-02-11
2020-09-30	$347,162,286	5,000,177	-1.2%	Shares	Defined	2020-11-13
2020-06-30	$331,528,315	5,063,047	+19.8%	Shares	Defined	2020-08-11
2020-03-31	$254,341,147	4,224,936	—	Shares	Defined	2020-05-12
No filing history on record for this holder in this stock.